Skip to content

Ketamine for Acute Suicidal Ideation in the Emergency Department: Randomized Controlled Trial

Ketamine for Acute Suicidal Ideation in the Emergency Department: Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01892995
Acronym
LDK-SI
Enrollment
53
Registered
2013-07-08
Start date
2015-06-30
Completion date
Unknown
Last updated
2015-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Suicide

Keywords

suicide, ketamine, low-dose ketamine, suicidal ideations, emergency department

Brief summary

This study will enroll patients presenting to the emergency department with acute suicidal ideation meeting inclusion and exclusion criteria. Patients will be randomized to one of three arms: ketamine (intervention) or diphenhydramine (control) or placebo (control). Serial measurements will be made in the ED and at follow-up intervals.

Interventions

DRUGKetamine

Sponsors

Brooke Army Medical Center
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients age 18 to less than 75 who present to the SAMMC ED with either overt or incidental suicidal ideations with a SADPERSONS score 5 or greater that the treating provider feels warrant formal evaluation.

Exclusion criteria

* -Poor vital sign stability hypoxia: O2 \< 95%, hypotension: SBP\< 90 hypertension: SBP\>180 Heart rate: \< 50 or \>120 Respiratory Rate: \<10 or \>30 * Altered mental status or intoxication * Patient is unwilling to participate or provide informed consent * Any allergy to ketamine or diphenhydramine * Patient is female of child-bearing age and unwilling to provide urine or blood for HCG analysis * Pregnancy or breast feeding * Presence of chronic oxygen-dependent pulmonary disease, liver cirrhosis, or renal disease requiring dialysis * Presence of ischemic heart disease, heart failure, or a history of unstable dysrhythmias * Presence of intracranial mass or vascular lesion. * Presence of a history of psychosis or hallucinations (as assessed by electronic chart review) * Weight greater than 115 kg or less than 45kg * History of increased intracranial pressure/hypertensive hydrocephalus * Non-English speaking patients * Patient is acutely psychotic * Provider feels that patient currently or likely will require chemical and/or physical restraints * History of prolonged QT-interval

Design outcomes

Primary

MeasureTime frame
Change in Beck Scale for Suicidal Ideation2 hours

Countries

United States

Contacts

Primary ContactSteven G Schauer, DO
sgschauer@gmail.com2109160808
Backup ContactShawn M Varney, DO
shawn.m.varney.mil@mail.mil2109160808

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026